Malignant Melanoma Stage II
1 clinical trials · Condition
◉ Watch Malignant Melanoma Stage II
| Record | Firm | Date |
|---|---|---|
| Adjuvant Nivolumab Treatment in Stage II (IIA, IIB, IIC) High-risk Melanoma (NCT04309409) | University Hospital, Essen | 2020-07-01 |
Track Malignant Melanoma Stage II automatically
Every clearance here is in the API, with alerts when new ones post.